2012 Conference

The 2012 conference took place in the Holiday Inn, Liverpool from 9-11 Nov
Where linked – click the title for presentation /abstract

Round tables

Plenary session

Short papers

Final feedback from research NPPG research grants 2010/2011



1.Use of concentrated potassium on PICU increased by the use of a balanced crystalloid Winner Special Products Innovation Award
2.Does profession or experience affect a practitioner’s perception when assigning potential harm avoided by pharmacists interventions
3.Experiences and opinions of non-medical prescribers in a paediatric hospital concerning electronic prescribing
4.Implementation of TTA pre-pack accreditation and training programme on paediatric wards
5.Parental understanding of dosing instructions for paracetamol and ibuprofen suspension
6.Glucose and Electrolyte Bags – How Accurately are they Prepared on the Neonatal Unit?
7.Epidemiology and potential associated risk factors of drug-related problems in hospitalised children in United Kingdom Winner Special products Best Poster Award
8.Post discharge follow up of children on long term medications
9.Adherence to general surgery prophylaxis guidelines at Alder Hey Children’s Hospital
10.The Impact of an Antibiotic Specific Prescription Form in the Accident and Emergency Department
11.The utility of the decision support tool FIRSTLight ™ in a paediatric hospital dispensary
12.Building a drug file for a clinical information management system – Grand designs or room to improve?
13.Standard concentration infusions and “Smart” pumps in PICU – the Challenge of Change
14.Audit of Medication Interventions made on the Paediatric Intensive Care Unit (PICU)
15.Prescribed antimicrobial therapy – What parents/carers are told and what they would like to know
16.An audit of paediatric ambulatory prescriptions
17.Paediatric Chemotherapy Prescribing – An Audit of Pharmacist Interventions
18.An Audit of Prescribing Errors in Neonates and Paediatrics
19.Audit on the Diagnosis and Management of Childhood Urinary Tract Infections (UTIs)
20.Intravenous Y-site Drug Administration on the Paediatric Intensive Care Unit
21.Ethanol Intake of Paediatric Intensive Care Patients
22.Manipulation of medicines to deliver a required dose: development of a good practice guideline
23.Safe and effective use of medicines in children: enhancing community pharmacists’ practice
24.Audit of the trust’s quality account antibiotic indicators for correct use in paediatrics
25. An Audit of Medicines Reconciliation in Paediatrics
26.Two Years Experience of the Treatment of Molybdenum Cofactor Deficiency
27.Investigation into the effect of Prasugrel versus Clopidogrel on platelet thromboelastography (TEG) analysis in Paediatric Patients on Ventricular Assistance Devices (VAD)
28.Discharge summaries on a Paediatric Assessment Unit (PAU): How accurate are the medications on discharge when there has been no pharmacy involvement?
29.Factors Affecting the Oxidative Degradation of Captopril in Oral Liquid Paediatric Formulations – a Factorial Design Study
30.A Matrix Decision Support Tool for the Development of Viable Paediatric Dosage Forms
31.Can ‘stock’ PN meet the requirements of the neonatal population?
32.Development of a taste-masked granule formulation of sodium phenylbutyrate adapted for paediatric use
33.Balanced maintenance fluids in PICU are safe and cost effective
34.An audit of electronic prescribing and administration of paediatric parenteral nutrition
35.A retrospective analysis of any trends in magnesium level for patients on omeprazole 10mg/5ml oral suspension from January to June 2012 (inclusive) in response to the MHRA Drug Safety Update April 2012